Hoxworth Blood Center & local arts organizations partner to make a lifesaving impact with blood drive at Music Hall
Hoxworth Blood Center, University of Cincinnati, is once again teaming up with local arts organizations to make an impact on the community with the Lifesaving as an Art Blood Drive.
The Cincinnati Arts Association, Cincinnati Ballet, Cincinnati Opera, May Festival, Cincinnati Pops Orchestra, Cincinnati Symphony Orchestra, and Friends of Music Hall are joining forces to help save lives in the community by hosting a blood drive in the ballroom at Music Hall on Tuesday, Feb. 28 from 10 a.m. to 4 p.m.
Donors will receive a free Hoxworth fleece blanket and other gifts from Music Hall sponsors. Donors will also get to enjoy live performances throughout the day.
Chris Milligan, Cincinnati Opera’s Harry Fath General Director & CEO, said, “Greater Cincinnatians have a long legacy of generosity—both in their support of the arts, and also in their support of their fellow community members. We’re grateful for the many ways our neighbors go above and beyond, and we’re proud to join our arts colleagues in bringing our community together around this important public health effort.”
Additionally, Hoxworth Blood Center wants to recognize the power of advocacy with the FDA’s recent draft guidance recommending a change from deferrals based on gender and sexual orientation to using gender-inclusive, individual risk-based questions to reduce the risk of transfusion-transmitted infection. Hoxworth donors have sent hundreds of post cards advocating for change in the FDA eligibility guidelines of the MSM deferral.
The FDA’s recommendations will be open for public comment for 60 days, closing March 31, 2023. The agency will then review and consider all comments before finalizing this guidance, which would then be implemented by the nation’s blood collection establishments through an updated donor history questionnaire (roughly 6-9 months).
Jackie Marschall, spokesperson for Hoxworth, added that Hoxworth currently has a critical need for type O Negative and A Negative blood donors and asks that any eligible individuals schedule a donation as early as possible.
Appointments for blood donation are highly encouraged due to the popularity of the event. Donors can schedule appointments by calling (513) 451-0910 or by scheduling online at www.hoxworth.org/groups/musichall.
Donors should enter the blood drive from the Box Office/Ballroom Entrance on Elm Street. For information about Music Hall parking, click here
About Hoxworth:
Hoxworth Blood Center, University of Cincinnati, was founded in 1938, and serves more than 30 hospitals in 18 counties in Southwestern Ohio, Northern Kentucky and Southeastern Indiana. Annually, Hoxworth collects more than 100,000 units of blood from local donors to help save the lives of patients in area hospitals. Hoxworth Blood Center: Saving Lives Close to Home.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.